Interactive Case Studies with the Experts: Improving VTE Prophylaxis in Hospitalized Oncology Patients
Faculty: Victor F. Tapson, MD, Andrew F. Shorr, MD, MPH, Vincent D. Pellegrini, Jr., MD
Format: Webcast
Credit Available: a maximum of 0.75 AMA PRA Category 1 Credit ™
Course Description: his program addresses key issues in the risk stratification and prevention of venous thromboembolism (VTE) in oncology patients and patients undergoing orthopaedic surgery in the form of two 30-minute interactive case studies. Each case study is presented by a specialist who cares for that subgroup of patients, then discussed with a nationally-recognized VTE expert.
Improving the Care of Patients With Non-Small Cell Lung Cancer: A Practical Guide for Performance Improvement
Faculty: Fred R. Hirsch, MD, PhD, Robert M. Jotte, MD, PhD
Format: Newsletter
Credit Available: a maximum of 1.5 AMA PRA Category 1 Credit ™
Course Description: This implementation guide is one of the educational activities available in Performance Improvement Strategies in Non-Small Cell Lung Cancer. This initiative offers a comprehensive series of activities designed to cover a broad range of topics on non-small cell lung cancer, with the ultimate goal of helping oncologists improve the care of patients with this condition. For additional information on this certified CME initiative or to view the other available activities, visit www.pi-iq.com/lungcancer.
Improving the Care of Patients with Colorectal Cancer: A Practical Guide for Performance Improvement
Faculty: Thomas H. Cartwright, MD, John L. Marshall, MD
Format: Newsletter
Credit Available: a maximum of 1.5 AMA PRA Category 1 Credit ™
Course Description: This implementation guide is one of the educational activities available in Performance Improvement Strategies in Colorectal Cancer. This initiative offers a comprehensive series of activities designed to cover a broad range of topics on colorectal cancer, with the ultimate goal of helping oncologists improve the care of patients with this condition. For additional information on this certified CME initiative or to view the other available activities, visit www.pi-iq.com/crc.
Oncologic Emergencies: Nephropathy and Tumor Lysis Syndrome
Faculty: Scott Howard, MD, MSc, Jorge E. Cortes, MD
Format: Webcast
Credit Available: a maximum of 1.0 AMA PRA Category 1 Credit ™
Course Description: Tumor lysis syndrome (TLS) is an oncologic emergency characterized by metabolic derangements resulting from tumor breakdown, which leads to a number of clinical manifestations including renal failure, fluid overload, edema, cardiac dysrhythmias, and sudden death. While TLS usually occurs after the initiation of cytotoxic therapy, it may occur spontaneously. Although the tumor-related risk factors known to contribute to TLS are common characteristics of hematological malignancies, TLS has recently been reported in patients with solid tumors and tumor types not typically associated with TLS. This program will focus on the identification and stratification of patients at risk of TLS, as well as the management of TLS once identified. Expert faculty will discuss preventing acute kidney injury in patients at risk of TLS and identifying treatment strategies based on patient risk factors. The practical application of current TLS prevention and management strategies will be discussed through case studies.
Case Studies in Oncologic Emergencies: Tumor Lysis Syndrome and Hemolysis in Acute Lymphoblastic Leukemia
Faculty: Scott Howard, MD, MSc
Format: Webcast
Credit Available: a maximum of 0.5 AMA PRA Category 1 Credit ™
Course Description: Tumor lysis syndrome (TLS) is an oncologic emergency characterized by metabolic derangements resulting from tumor breakdown, which leads to a number of clinical manifestations including renal failure, fluid overload, edema, cardiac dysrhythmias, and sudden death. While TLS usually occurs after the initiation of cytotoxic therapy, it may occur spontaneously. Although the tumor-related risk factors known to contribute to TLS are common characteristics of hematological malignancies, TLS has recently been reported in patients with solid tumors and tumor types not typically associated with TLS. This program will focus on the identification and stratification of patients at risk of TLS, as well as the management of TLS once identified. Expert faculty will discuss preventing acute kidney injury in patients at risk of TLS and identifying treatment strategies based on patient risk factors. The practical application of current TLS prevention and management strategies will be discussed through case studies.
